Cargando…

PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes

Neurodegenerative parkinsonian syndromes comprise a number of disorders that are characterized by similar clinical features but are separated on the basis of different pathologies, i.e., aggregates of α-synuclein or tau protein. Due to the overlap of signs and symptoms a precise differentiation is o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schönecker, Sonja, Brendel, Matthias, Palleis, Carla, Beyer, Leonie, Höglinger, Günter U., Schuh, Elisabeth, Rauchmann, Boris-Stephan, Sauerbeck, Julia, Rohrer, Guido, Sonnenfeld, Stefan, Furukawa, Katsutoshi, Ishiki, Aiko, Okamura, Nobuyuki, Bartenstein, Peter, Dieterich, Marianne, Bötzel, Kai, Danek, Adrian, Rominger, Axel, Levin, Johannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749151/ https://www.ncbi.nlm.nih.gov/pubmed/31572166 http://dx.doi.org/10.3389/fnagi.2019.00249

Ejemplares similares

[(18)F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy
por: Brendel, Matthias, et al.
Publicado: (2018)

Dual-Phase β-Amyloid PET Captures Neuronal Injury and Amyloidosis in Corticobasal Syndrome
por: Schmitt, Julia, et al.
Publicado: (2021)

Cognitive reserve hypothesis in frontotemporal dementia: A FDG-PET study
por: Beyer, Leonie, et al.
Publicado: (2020)

Impact of Partial Volume Correction on [(18)F]GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal Syndrome
por: Schuster, Sebastian, et al.
Publicado: (2022)

Detection Gap of Right-Asymmetric Neuronal Degeneration by CERAD Test Battery in Alzheimer’s Disease
por: Kreuzer, Annika, et al.
Publicado: (2021)

Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?
por: Beyer, Leonie, et al.
Publicado: (2018)

Assessment of perfusion deficit with early phases of [(18)F]PI-2620 tau-PET versus [(18)F]flutemetamol-amyloid-PET recordings
por: Völter, Friederike, et al.
Publicado: (2022)

Perfusion-Phase [(18)F]THK5351 Tau-PET Imaging as a Surrogate Marker for Neurodegeneration
por: Brendel, Matthias, et al.
Publicado: (2017)

Applied multimodal diagnostics in a case of presenile dementia
por: Schönecker, Sonja, et al.
Publicado: (2016)

Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease
por: Beyer, Leonie, et al.
Publicado: (2019)

Juveniler Parkinson und Mikrodeletionssyndrom 22q11.2
por: Palleis, Carla, et al.
Publicado: (2023)

Development of geriatric syndromes after taking countermeasures for polypharmacy: an overlooked issue of quitting semiregular single-dose medicine
por: Tomita, Naoki, et al.
Publicado: (2019)

[(18)F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data
por: Ballweg, Anna, et al.
Publicado: (2023)

Engraftment of Mouse Embryonic Stem Cells Differentiated by Default Leads to Neuroprotection, Behaviour Revival and Astrogliosis in Parkinsonian Rats
por: Tripathy, Debasmita, et al.
Publicado: (2013)

Imaging of Reactive Astrogliosis by Positron Emission Tomography
por: Harada, Ryuichi, et al.
Publicado: (2022)

Early-phase [(18)F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury
por: Beyer, Leonie, et al.
Publicado: (2020)

Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [(18)F]-PI-2620 tau-PET signal
por: Schönecker, Sonja, et al.
Publicado: (2023)

Impact of TSPO Receptor Polymorphism on [(18)F]GE-180 Binding in Healthy Brain and Pseudo-Reference Regions of Neurooncological and Neurodegenerative Disorders
por: Vettermann, Franziska J., et al.
Publicado: (2021)

Astrogenesis versus astrogliosis
por: Koob, Andrew O.
Publicado: (2017)

Colocalization of Tau but Not β-Amyloid with Cortical Superficial Siderosis in a Case with Probable CAA
por: Brendel, Matthias, et al.
Publicado: (2020)

Assessment of (18)F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy
por: Brendel, Matthias, et al.
Publicado: (2020)

Deep Brain Stimulation Programming 2.0: Future Perspectives for Target Identification and Adaptive Closed Loop Stimulation
por: Hell, Franz, et al.
Publicado: (2019)

Establishment of a Visual Analog Scale for DBS Programming (VISUAL-STIM Trial)
por: Palleis, Carla, et al.
Publicado: (2020)

Deep Brain Stimulation Programming for Movement Disorders: Current Concepts and Evidence-Based Strategies
por: Koeglsperger, Thomas, et al.
Publicado: (2019)

Molar loss induces hypothalamic and hippocampal astrogliosis in aged mice
por: Furukawa, Masae, et al.
Publicado: (2022)

Region-specific astrogliosis: differential vessel formation contributes to different patterns of astrogliosis in the cortex and striatum
por: Yang, Haijie, et al.
Publicado: (2020)

Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases
por: Biechele, Gloria, et al.
Publicado: (2020)

Additive value of [(18)F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome
por: Katzdobler, Sabrina, et al.
Publicado: (2022)

Investigation of reactive astrogliosis effect on post-stroke cognitive impairment
por: Huang, Kuo-Lun, et al.
Publicado: (2020)

Author Correction: Molar loss induces hypothalamic and hippocampal astrogliosis in aged mice
por: Furukawa, Masae, et al.
Publicado: (2022)

Sulfasalazine decreases astrogliosis‐mediated seizure burden
por: Alcoreza, Oscar, et al.
Publicado: (2022)

Reactive astrogliosis in the era of single-cell transcriptomics
por: Matusova, Zuzana, et al.
Publicado: (2023)

Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects()()
por: Ewers, Michael, et al.
Publicado: (2013)

The development and validation of tau PET tracers: current status and future directions
por: Okamura, Nobuyuki, et al.
Publicado: (2018)

Longitudinal Assessment of Tau Pathology in Patients with Alzheimer’s Disease Using [(18)F]THK-5117 Positron Emission Tomography
por: Ishiki, Aiko, et al.
Publicado: (2015)

(68)Ga-EMP-100 PET/CT—a novel method for non-invasive assessment of c-MET expression in non-small cell lung cancer
por: Unterrainer, Lena M., et al.
Publicado: (2022)

Binding characteristics of [(18)F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET
por: Song, Mengmeng, et al.
Publicado: (2021)

Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer’s Disease Patients Measured Using [18F] THK-5351
por: Lockhart, Samuel N., et al.
Publicado: (2016)

Non-invasive quantification of brain tumor-induced astrogliosis
por: Lee, Jisook, et al.
Publicado: (2011)

The Role of Astrogliosis in Formation of the Syrinx in Spinal Cord Injury
por: Kwiecien, Jacek M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s396tq25oqq895eh7n8sj83f1p